Medixine has appointed new members to its Advisory Board: Finnish technology and healthcare industry veterans Kai Öistämö and Anssi Ylimaula. The new members bring extensive expertise and international experience, perfectly complementing the contributions of the previously announced U.S. member, Peter Alperin.
Peter Alperin, a Texas-based internal medicine physician and healthcare technology pioneer, is notably recognized for his role as Vice President of Product at Doximity, which went public in 2021, reaching a market capitalization of $9 billion.
Kai Öistämö has served as the President and CEO of Vaisala, a global leader in weather, environmental, and industrial measurement solutions, since October 2020. He holds a PhD in Computer Science from Tampere University of Technology (1992). Prior to Vaisala, Öistämö was the Chief Operating Officer at InterDigital (2018–2020) and an Executive Partner at Siris Capital Group (2016–2018). He also had a long career at Nokia, where he held key roles such as Executive Vice President of Devices (2008–2010) and Chief Development Officer (2010–2014). Additionally, he has been a member of Nokia’s Board of Directors since 2022. Öistämö’s deep experience in technology leadership, strategic development, and international business enhances the Advisory Board’s ability to support the company’s growth.
Anssi Ylimaula is a Finnish entrepreneur and MedTech veteran who, since 2000, has been instrumental in founding four startup companies. The largest of these grew into an international player with 250 employees. In 2015, he founded Kide Systems, which was acquired by the Japanese publicly traded company Topcon in 2018. Following the acquisition, Ylimaula served as Managing Director of Topcon Healthcare Solutions EMEA Oy, initially overseeing operations in Europe, the Middle East, and Africa, and later expanding his responsibilities globally. Today, he is an active investor, advisor, and board member for growth companies, as well as a mentor focusing on digitalization, leadership, and internationalization. Ylimaula’s hands-on expertise in healthcare technology, particularly in scaling growth companies internationally, brings significant value to Medixine’s development.
Medixine continues its work to bring its innovative Finnish digital health product to global markets, and the Advisory Board supports this ambition by uniting top experts from diverse fields.